Study Of Drug Related Problems (DRPS) In Outpatients Of Type II Diabetes Mellitus With Hypertension In Doloksanggul Regional Hospital

by ADMIN 134 views

Study of Drug-Related Problems (DRPS) in Outpatients of Type II Diabetes Mellitus with Hypertension in Doloksanggul Regional Hospital

Introduction

Diabetes mellitus is a chronic and degenerative disease characterized by glucose metabolic disorders, which can trigger hypertension. On the other hand, hypertension can also cause insulin resistance, making it a complex condition to manage. Patients with type 2 diabetes mellitus who also suffer from hypertension require prolonged drug therapy, which not only affects their quality of life but also has the potential to cause various drug-related problems (DRPs). This study aims to analyze DRPs in outpatients and evaluate the impact of intervention on DRPs, clinical results, kidney function, compliance levels, and the quality of life of patients.

Background

Diabetes mellitus is a major public health concern worldwide, affecting millions of people. The disease is characterized by high blood sugar levels, which can lead to various complications, including hypertension. Hypertension, on the other hand, is a major risk factor for cardiovascular disease, kidney disease, and stroke. The combination of diabetes mellitus and hypertension requires patients to undergo prolonged drug therapy, which can lead to various DRPs. These DRPs can include medication errors, adverse drug reactions, and non-adherence to medication, among others.

Research Methods

This study uses a quasi-experimental approach and involves 42 outpatients with type 2 diabetes mellitus and hypertension treated at Doloksanggul Regional Hospital in the period July to December 2018. To identify DRPs, an instrument from Pharmaceutical Care Network Europe version 8.01 was used. The quality of life of patients was considered using the Diabetes Quality of Life (DQOL) questionnaire, while the level of compliance was measured through the Morisky Medication Adherence Scale (MMAS-8) questionnaire. Data collected before and after intervention was analyzed using SPSS software version 22.

Research Result

The results showed that the intervention given succeeded in reducing the average DRPs to 1.38 ± 1.01. The average blood glucose level also decreased to 206.83 ± 54.52 mg/dl. In addition, as many as 28 patients (67%) succeeded in achieving the desired blood pressure. The patient's kidney function was also maintained, with 39 patients (93%) reaching normal ureum levels and 28 patients (67%) with serum creatinine levels within normal limits. The patient's compliance rate has increased an average of 1.76 ± 0.17, showing high compliance, while the quality of life increases to 91.07 ± 1.17, signifying good quality of life.

Analysis and Conclusion

This study found a significant difference (p <0.005) in the incidence of DRPs, clinical results, kidney function, compliance level, and quality of life of patients between before and after intervention. This shows that the interventions carried out are not only effective in reducing DRPs, but also contributing positively to the management of diabetes mellitus and hypertension in patients. Increased compliance and quality of life that significantly reflects the importance of the role of health interventions in supporting patients to comply with drug therapy and achieve better quality of life.

Implications of the Study

This study underlines the need for better drug management strategies in handling type 2 diabetes mellitus patients who have hypertension to minimize the risk of DRPs and improve overall clinical outcomes. The results of this study can be a reference for health workers in managing the therapy of diabetes mellitus patients with hypertension, as well as improving the quality of health services in Doloksanggul Regional Hospital and other health facilities.

Recommendations

Based on the findings of this study, the following recommendations are made:

  1. Improved drug management strategies: Health workers should develop and implement better drug management strategies to minimize the risk of DRPs and improve overall clinical outcomes.
  2. Increased patient education: Patients with type 2 diabetes mellitus and hypertension should be educated on the importance of adhering to medication and the potential risks of DRPs.
  3. Regular monitoring: Regular monitoring of patients with type 2 diabetes mellitus and hypertension should be conducted to identify potential DRPs and prevent complications.
  4. Collaboration between healthcare providers: Collaboration between healthcare providers, including pharmacists, doctors, and nurses, is essential to ensure that patients receive comprehensive care and minimize the risk of DRPs.

Limitations of the Study

This study has several limitations, including:

  1. Small sample size: The sample size of this study is relatively small, which may limit the generalizability of the findings.
  2. Short duration: The duration of this study is relatively short, which may not capture the long-term effects of the interventions.
  3. Limited scope: This study only focuses on patients with type 2 diabetes mellitus and hypertension, which may not be representative of the broader population.

Future Research Directions

Future research should focus on:

  1. Long-term effects: Long-term effects of the interventions should be studied to determine the sustainability of the results.
  2. Broader population: The study should be replicated in a broader population to determine the generalizability of the findings.
  3. Different interventions: Different interventions should be studied to determine their effectiveness in reducing DRPs and improving clinical outcomes.

Conclusion

In conclusion, this study found that the intervention given succeeded in reducing the average DRPs, improving clinical results, kidney function, compliance levels, and quality of life of patients with type 2 diabetes mellitus and hypertension. The results of this study highlight the importance of health interventions in supporting patients to comply with drug therapy and achieve better quality of life.
Q&A: Study of Drug-Related Problems (DRPS) in Outpatients of Type II Diabetes Mellitus with Hypertension in Doloksanggul Regional Hospital

Q: What is the main objective of this study?

A: The main objective of this study is to analyze drug-related problems (DRPs) in outpatients with type 2 diabetes mellitus and hypertension, and to evaluate the impact of intervention on DRPs, clinical results, kidney function, compliance levels, and the quality of life of patients.

Q: What is the significance of this study?

A: This study is significant because it highlights the importance of health interventions in supporting patients to comply with drug therapy and achieve better quality of life. The study also underlines the need for better drug management strategies in handling type 2 diabetes mellitus patients who have hypertension to minimize the risk of DRPs and improve overall clinical outcomes.

Q: What are the limitations of this study?

A: The limitations of this study include a small sample size, short duration, and limited scope. The study only focuses on patients with type 2 diabetes mellitus and hypertension, which may not be representative of the broader population.

Q: What are the implications of this study?

A: The implications of this study are that health workers should develop and implement better drug management strategies to minimize the risk of DRPs and improve overall clinical outcomes. Patients with type 2 diabetes mellitus and hypertension should be educated on the importance of adhering to medication and the potential risks of DRPs.

Q: What are the recommendations of this study?

A: The recommendations of this study include:

  1. Improved drug management strategies: Health workers should develop and implement better drug management strategies to minimize the risk of DRPs and improve overall clinical outcomes.
  2. Increased patient education: Patients with type 2 diabetes mellitus and hypertension should be educated on the importance of adhering to medication and the potential risks of DRPs.
  3. Regular monitoring: Regular monitoring of patients with type 2 diabetes mellitus and hypertension should be conducted to identify potential DRPs and prevent complications.
  4. Collaboration between healthcare providers: Collaboration between healthcare providers, including pharmacists, doctors, and nurses, is essential to ensure that patients receive comprehensive care and minimize the risk of DRPs.

Q: What are the future research directions of this study?

A: The future research directions of this study include:

  1. Long-term effects: Long-term effects of the interventions should be studied to determine the sustainability of the results.
  2. Broader population: The study should be replicated in a broader population to determine the generalizability of the findings.
  3. Different interventions: Different interventions should be studied to determine their effectiveness in reducing DRPs and improving clinical outcomes.

Q: What are the potential applications of this study?

A: The potential applications of this study include:

  1. Improved patient care: The study can be used to improve patient care by developing and implementing better drug management strategies.
  2. Reduced healthcare costs: The study can be used to reduce healthcare costs by minimizing the risk of DRPs and improving clinical outcomes.
  3. Enhanced quality of life: The study can be used to enhance the quality of life of patients with type 2 diabetes mellitus and hypertension by improving their compliance levels and clinical outcomes.

Q: What are the potential limitations of applying the findings of this study?

A: The potential limitations of applying the findings of this study include:

  1. Generalizability: The study may not be generalizable to other populations, such as patients with type 1 diabetes mellitus or those with different comorbidities.
  2. Contextual factors: The study may not account for contextual factors, such as cultural or socioeconomic factors, that may influence the effectiveness of the interventions.
  3. Resource constraints: The study may not account for resource constraints, such as limited access to healthcare services or medications, that may influence the effectiveness of the interventions.